Gliclazide, a sulfonlyurea class molecule, is used to control glycaemi
c levels in non insulin-dependent diabetes mellitus, acute and chronic
toxicity studies, conducted in various animal species, have demonstra
ted a very low toxicity. We report a patient who developed acute renal
failure due to acute tubular necrosis following a massive ingestion o
f gliclazide in an suicide attempt. The patient ingested 28 grams of g
liclazide, the normal dose of gliclazide is 80 mg one or once a day. A
l admission the patient was hypoglycaemia and in a few days became oli
guric with an increase in the serum creatinine concentration but with
a normal blood urea nitrogen level. He underwent dialysis and ten days
after ingestion of gliclazide, his renal function improved rapidly.